COSTA, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 1.807
AS - Asia 1.724
EU - Europa 1.459
SA - Sud America 239
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.280
Nazione #
US - Stati Uniti d'America 1.739
SG - Singapore 966
RU - Federazione Russa 880
CN - Cina 380
BR - Brasile 190
IT - Italia 185
HK - Hong Kong 143
VN - Vietnam 119
NL - Olanda 102
DE - Germania 80
FI - Finlandia 61
CA - Canada 41
GB - Regno Unito 34
IN - India 33
AR - Argentina 23
FR - Francia 23
SE - Svezia 23
PL - Polonia 20
MX - Messico 16
ID - Indonesia 15
CI - Costa d'Avorio 13
ZA - Sudafrica 13
BD - Bangladesh 12
IE - Irlanda 12
JP - Giappone 11
TR - Turchia 10
EC - Ecuador 8
LT - Lituania 8
UA - Ucraina 7
ES - Italia 6
KR - Corea 6
IQ - Iraq 5
MA - Marocco 5
CO - Colombia 4
DZ - Algeria 4
IL - Israele 4
VE - Venezuela 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BE - Belgio 2
CR - Costa Rica 2
GR - Grecia 2
IR - Iran 2
PA - Panama 2
SA - Arabia Saudita 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
NC - Nuova Caledonia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
SD - Sudan 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.280
Città #
Singapore 445
Chandler 272
Moscow 201
Ashburn 187
Beijing 147
Hong Kong 143
Dallas 139
Santa Clara 111
Amsterdam 95
Napoli 70
Los Angeles 57
Millbury 53
Ho Chi Minh City 49
Boston 47
Des Moines 43
Lawrence 39
Helsinki 36
Buffalo 32
New York 29
Nanjing 26
Falkenstein 24
Munich 22
Ottawa 22
Redondo Beach 22
Hefei 21
Hanoi 20
Princeton 20
The Dalles 20
Kochi 17
Naples 16
São Paulo 15
Warsaw 15
Washington 15
Wilmington 15
Turku 14
Montreal 11
Tokyo 11
Brooklyn 10
Hebei 9
Johannesburg 9
Nanchang 9
Seattle 9
Dong Ket 8
Fairfield 8
Houston 8
Orem 8
Stockholm 8
Guangzhou 7
Phoenix 7
Poplar 7
Chicago 6
Rio de Janeiro 6
Shenyang 6
Tianjin 6
Atlanta 5
Chennai 5
Frankfurt am Main 5
Grammichele 5
Guayaquil 5
Jiaxing 5
London 5
Mexico City 5
Querétaro 5
Seoul 5
Toronto 5
Changsha 4
Da Nang 4
Düsseldorf 4
Haiphong 4
Jakarta 4
Manchester 4
Redwood City 4
Rome 4
San Francisco 4
Wuhan 4
Ankara 3
Biên Hòa 3
Campinas 3
Charlotte 3
Chengdu 3
Copenhagen 3
Cordaleo 3
Denver 3
Dhaka 3
Goiânia 3
Kieźliny 3
Lappeenranta 3
Lauterbourg 3
Mumbai 3
Quito 3
Salerno 3
Tampa 3
Woodbridge 3
Aegina 2
Ann Arbor 2
Annapolis 2
Anápolis 2
Arlington 2
Asti 2
Baghdad 2
Totale 2.815
Nome #
A case of the co-existence of subcorneal pustular dermatosis and pyoderma gangrenosum and a review of the literature 157
Clinical and dermoscopic features of Spitz nevus by sex, age and anatomical site: a study of 913 Spitz naevi 128
Dermoscopy of uncommon variants of dermatofibrosarcoma protuberans 124
How reflectance confocal microscopy can help diagnose an enigmatic variant of dermatofibroma 118
An atypical pigmented lesion-Answer. 116
Vismodegib treatment in a HIV positive patient on antiretroviral therapy 116
Molluscum contagiosum arising next to a scar of the nipple of an excised mammarian fibroadenoma and brief review of literature 115
A rare evolution of porokeratosis 115
Squamous Cell Carcinomas in Two Cases of Nail Lichen Planus: Is There a Real Association? 114
Nevoid hyperkeratosis of the nipple mimicking a pigmented basal cell carcinoma 112
Leiomyoma of the finger in a patient affected by cutaneous Kaposi's sarcoma 112
Reply to Woltsche N. et al. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single center experience 112
Ingenol Mebutate: When the Patient Refuses Surgery 110
Cutaneous Bowen’s disease: An analysis of 182 cases according to age, sex, and anatomical site from an Italian center 110
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families 110
Tissue Expression of Carbonic Anhydrase IX Correlates to More Aggressive Phenotype of Basal Cell Carcinoma 110
An atypical pigmented lesion. 109
Chronic inducible urticarias in children 109
Difficult to diagnose small cutaneous melanoma metastases mimicking angiomas: utility of dermoscopy 109
Appearances may be deceiving 108
Management of clinical and subclinical actinic keratoses with histological and immunohistochemical assessments by confocal microscopy 108
Effective and tolerable treatment of advanced basal cell carcinoma with vismodegib despite other malignancies 108
Clinical, dermoscopic and histological features of a Merkel cell carcinoma of the hand. 106
Neutrophilic dermatosis in pregnancy: An uncommon course 104
Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience 103
Double extramammary Paget's disease 101
Dermoscopic patterns of intradermal naevi 100
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test 99
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience 99
Lichenoid rash: A new side effect of oral Cladribine 99
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity 97
A case of Paediatric Acrodermatitis Continua of Hallopeau successfully treated with adalimumab biosimilar 96
Ein solitärer rötlicher Knoten am oberen Rücken einer Frau mittleren Alters. 95
Deceitful clustered papules on the scalp of a middle-aged woman 94
A solitary reddish nodule on the upper back of a middle-aged woman 91
Melanoma frequency among symmetrical Spitzoid-looking lesions: a retrospective study 90
The remarkable increase of squamous cell carcinomas: a retrospective single-center study of 14-years study period 88
BRIT‐1 expression and its relationship with PARP‐1 and CAF‐1/p60 in cutaneous melanoma 86
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study 86
Cutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective study 85
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" 81
Waste exposure and skin diseases 78
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire 75
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic 74
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 70
Second primary melanoma: incidence rate and risk factors 67
Comment on: “Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring” 65
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients 61
A case of juvenile amyopathic dermatomyositis 60
Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experience 59
Hailey-Hailey disease successfully treated with vitamin D oral supplementation 56
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies 56
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma 54
Dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor sonidegib to manage adverse effects: A retrospective case series 49
SkIndia Quiz 32: A strange sessile formation appearing as a penis-like structure 45
Hair Loss in Patients Treated with Vismodegib: A Single-Center Retrospective Study 44
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment 39
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt 39
Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months" 39
Drug holiday regimen for vismodegib treatment in patients with multiple primary basal cell carcinomas 32
Totale 5.392
Categoria #
all - tutte 18.127
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.127


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 8 6 63 3 24 4 8
2021/2022335 0 0 11 1 2 12 3 8 20 31 95 152
2022/2023576 70 72 18 23 84 50 0 54 81 86 28 10
2023/2024309 12 53 27 24 23 58 1 29 1 10 59 12
2024/20251.784 103 73 1 24 76 98 149 142 80 209 670 159
2025/20261.977 344 216 438 317 579 83 0 0 0 0 0 0
Totale 5.392